1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biological Indicators Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biological Indicators Market Revenue and Volume, by Product/Type
8.1.1 Self-Contained Biological Indicators
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Biological Indicator Strips
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Cards / Rapid Readout BIs
8.1.3.1. Market Revenue and Volume Forecast
9.1. Biological Indicators Market Revenue and Volume, by Sterilization Method
9.1.1. Steam Sterilization
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Ethylene Oxide Sterilization
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Hydrogen Peroxide Sterilization
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Other Methods (plasma, dry heat)
9.1.4.1. Market Revenue and Volume Forecast
10.1. Biological Indicators Market Revenue and Volume, by End Use / Application
10.1.1. Breakdown reflects common reported application groups.
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Au Hospitals & Clinics tomotive
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Pharmaceutical Companies / Biopharma
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Research Laboratories / Other Users
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product/Type
11.1.2. Market Revenue and Volume Forecast, by Sterilization Method
11.1.3. Market Revenue and Volume Forecast, by End Use / Application
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product/Type
11.1.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.1.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product/Type
11.1.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.1.5.3. Market Revenue and Volume Forecast, by End Use / Application
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product/Type
11.2.2. Market Revenue and Volume Forecast, by Sterilization Method
11.2.3. Market Revenue and Volume Forecast, by End Use / Application
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product/Type
11.2.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.2.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product/Type
11.2.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.2.5.3. Market Revenue and Volume Forecast, by End Use / Application
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product/Type
11.2.6.2. Market Revenue and Volume Forecast, by Sterilization Method
11.2.6.3. Market Revenue and Volume Forecast, by End Use / Application
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product/Type
11.2.7.2. Market Revenue and Volume Forecast, by Sterilization Method
11.2.7.3. Market Revenue and Volume Forecast, by End Use / Application
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product/Type
11.3.2. Market Revenue and Volume Forecast, by Sterilization Method
11.3.3. Market Revenue and Volume Forecast, by End Use / Application
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product/Type
11.3.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.3.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product/Type
11.3.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.3.5.3. Market Revenue and Volume Forecast, by End Use / Application
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product/Type
11.3.6.2. Market Revenue and Volume Forecast, by Sterilization Method
11.3.6.3. Market Revenue and Volume Forecast, by End Use / Application
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product/Type
11.3.7.2. Market Revenue and Volume Forecast, by Sterilization Method
11.3.7.3. Market Revenue and Volume Forecast, by End Use / Application
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product/Type
11.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product/Type
11.4.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.4.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product/Type
11.4.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.4.5.3. Market Revenue and Volume Forecast, by End Use / Application
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product/Type
11.4.6.2. Market Revenue and Volume Forecast, by Sterilization Method
11.4.6.3. Market Revenue and Volume Forecast, by End Use / Application
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product/Type
11.4.7.2. Market Revenue and Volume Forecast, by Sterilization Method
11.4.7.3. Market Revenue and Volume Forecast, by End Use / Application
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product/Type
11.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.5.3. Market Revenue and Volume Forecast, by End Use / Application
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product/Type
11.5.4.2. Market Revenue and Volume Forecast, by Sterilization Method
11.5.4.3. Market Revenue and Volume Forecast, by End Use / Application
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product/Type
11.5.5.2. Market Revenue and Volume Forecast, by Sterilization Method
11.5.5.3. Market Revenue and Volume Forecast, by End Use / Application
12.1. 3M
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. STERIS plc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Getinge Group
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Mesa Laboratories, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cantel Medical (Sotera Health)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Terragene S.A.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Tuttnauer
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ecolab Inc. / Bioquell
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Fuze Medical / Fuze Medicine Equipment
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Hu-Friedy
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
